Saturday, December 5

Coronavirus: The United States approves the emergency use of Regeneron, the experimental treatment that Trump received when he tested positive

  • Drafting
  • BBC World News


The Regeneron treatment uses monoclonal antibodies.

The United States Food and Drug Administration (FDA) authorized the emergency use of the experimental antibody treatment that was administered to President Trump when he was diagnosed with Covid-19.

The use of the drug, developed by Regeneron, will be allowed in people who have tested positive for coronavirus and are at risk of contracting a serious illness.

A emergency clearance allows the use of a treatment even if studies have not been completed to determine its safety and efficacy.

But according to the company its reports suggest that the therapy is effective when administered after an early diagnosis of Covid-19.

style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">

Leave a Reply

Your email address will not be published. Required fields are marked *